Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.

Current pharmaceutical biotechnology - 1 Jun 2006

Anensen Nina, Haaland Ingvild, D'Santos Clive, Van Belle Werner, Gjertsen Bjørn Tore

Abstract excerpt

The anti-oncogene TP53 is frequently mutated in human cancer, but in hematological malignancies this is a rare feature. In acute myeloid leukemia (AML) more than 90% of the patients comprise wild type TP53 in their cancer cells, but if TP53 is mutated or deleted the disease is often found to be c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acetylation
Share to Acute Disease
Share to Leukemia, Myeloid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phosphorylation

Share to Proteomics

Share to Signal Transduction

Share to Tumor Suppressor Protein p53

Share to Ubiquitins

Source

Identifiers

PMID: 16789904
DOI: 10.2174/138920106777549731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16789904-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.PMID 16789904Read ↗

p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status.Semantic proximity Read ↗

Uncovering the role of p53 splice variants in human malignancy: a clinical perspectiveSemantic proximity Read ↗

The TP53 tumor suppressor gene: From molecular biology to clinical investigationsSemantic proximity Read ↗

The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases.Semantic proximity Read ↗

Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms.Semantic proximity Read ↗

Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy.Semantic proximity Read ↗

p53: an overview of over two decades of study.Semantic proximity Read ↗

A Distinct p53 Protein Isoform Signature Reflects the Onset of Induction Chemotherapy for Acute Myeloid LeukemiaSemantic proximity Read ↗

Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53Semantic proximity Read ↗

p53 Isoforms as Cancer Biomarkers and Therapeutic TargetsSemantic proximity Read ↗

Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysisSemantic proximity Read ↗

The p53 pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.